Genetic and molecular testing updates

Starting Jan. 1, 2022, we’ll require prior authorization for additional genetic and molecular testing CPT®  codes for our commercial plan members.

This is a part of the prior authorization program for genetic and molecular testing performed in an outpatient setting.

You can learn more about submitting your prior authorization requests by reviewing our Genetic and molecular lab testing notification/prior authorization process FAQs.

Questions?
Visit the Genetic and molecular lab testing notification/prior authorization page.

CPT® is a registered trademark of the American Medical Association. 
PCA-1-21-03454-VC-News